Philippe Verwaerde
Chief Executive Officer at AlzProtect SAS
Profile
Philippe Verwaerde is the founder of Vivactis SAS, AlzProtect SAS, iNovacia AB.
He previously worked as a Principal at deVGen NV, Genfit SA, Organon SA, and Glaxo Wellcome SA.
Philippe Verwaerde active positions
| Companies | Position | Start |
|---|---|---|
AlzProtect SAS
 AlzProtect SAS Miscellaneous Commercial ServicesCommercial Services AlzProtect SAS operates as a biotechnological company. It develops therapeutical solutions for neurodegenerative diseases. The company was founded by Andre Delacourt and Patricia Melnyk in November 2007 and is headquartered in Loos, France. | Chief Executive Officer | - |
Former positions of Philippe Verwaerde
| Companies | Position | End |
|---|---|---|
| Organon SA | Corporate Officer/Principal | - |
| GENFIT | Corporate Officer/Principal | - |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - |
Glaxo Wellcome SA
 Glaxo Wellcome SA Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Glaxo Wellcome SA is a Spanish company that manufactures and markets medicines. The company is based in Aranda de Duero, Spain. | Corporate Officer/Principal | - |
iNovacia AB
 iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GENFIT | Health Technology |
| Private companies | 6 |
|---|---|
Vivactis SAS
 Vivactis SAS Miscellaneous Commercial ServicesCommercial Services Vivactis SAS specializes in healthcare communications and marketing services. The company is based in Neuilly-sur-Seine, France. The French company was founded by Jean-Claude Sauli, Philippe Verwaerde. Vivactis was acquired by Vivactis Group SA on February 29, 2008. | Commercial Services |
iNovacia AB
iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Commercial Services |
AlzProtect SAS
AlzProtect SAS Miscellaneous Commercial ServicesCommercial Services AlzProtect SAS operates as a biotechnological company. It develops therapeutical solutions for neurodegenerative diseases. The company was founded by Andre Delacourt and Patricia Melnyk in November 2007 and is headquartered in Loos, France. | Commercial Services |
Glaxo Wellcome SA
Glaxo Wellcome SA Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Glaxo Wellcome SA is a Spanish company that manufactures and markets medicines. The company is based in Aranda de Duero, Spain. | Health Technology |
deVGen NV
deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Health Technology |
| Organon SA |
- Stock Market
- Insiders
- Philippe Verwaerde
